- Home
- TMC vs ENGN Comparison
TMC vs ENGN Comparison
Compare TMC & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMC
- ENGN
- Stock Information
- Founded
- TMC 2011
- ENGN 1999
- Country
- TMC Canada
- ENGN Canada
- Employees
- TMC N/A
- ENGN N/A
- Industry
- TMC Metal Mining
- ENGN
- Sector
- TMC Basic Materials
- ENGN
- Exchange
- TMC Nasdaq
- ENGN Nasdaq
- Market Cap
- TMC 340.2M
- ENGN 293.1M
- IPO Year
- TMC N/A
- ENGN N/A
- Fundamental
- Price
- TMC $0.98
- ENGN $8.58
- Analyst Decision
- TMC Hold
- ENGN Strong Buy
- Analyst Count
- TMC 1
- ENGN 6
- Target Price
- TMC $4.00
- ENGN $33.67
- AVG Volume (30 Days)
- TMC 536.2K
- ENGN 128.7K
- Earning Date
- TMC 11-15-2024
- ENGN 09-10-2024
- Dividend Yield
- TMC N/A
- ENGN N/A
- EPS Growth
- TMC N/A
- ENGN N/A
- EPS
- TMC N/A
- ENGN N/A
- Revenue
- TMC N/A
- ENGN N/A
- Revenue This Year
- TMC N/A
- ENGN N/A
- Revenue Next Year
- TMC N/A
- ENGN N/A
- P/E Ratio
- TMC N/A
- ENGN N/A
- Revenue Growth
- TMC N/A
- ENGN N/A
- 52 Week Low
- TMC $0.80
- ENGN $4.42
- 52 Week High
- TMC $2.07
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- TMC 48.29
- ENGN 51.13
- Support Level
- TMC $0.93
- ENGN $8.50
- Resistance Level
- TMC $1.01
- ENGN $9.06
- Average True Range (ATR)
- TMC 0.03
- ENGN 0.71
- MACD
- TMC 0.00
- ENGN -0.12
- Stochastic Oscillator
- TMC 67.45
- ENGN 1.02
About TMC TMC the metals company Inc.
TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Geographically, the company has its presence in Nauru, Singapore, Tonga and North America. The CCZ is a geological submarine fracture zone of abyssal plains and other formations in the Eastern Pacific Ocean, with a length of around 7,240 kilometers (4,500 miles) that spans approximately 4,500,000 square kilometers (1,700,000 square miles).
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.